Examen de radiation de la TSX - Antibe Therapeutics Inc. (ATE)
| Issuer: | Antibe Therapeutics Inc. | 
| Securities: | Common shares (the "Shares") | 
| Symbol(s): | ATE | 
| Delisting Date: | May 24, 2024 (at the close) | 
| Reason: | Failure to meet continued listing requirements. | 
| Trading: | The Shares will remain suspended from trading. | 
| Additional Information: | TSX Bulletin 2024-0219 dated April 9, 2024. | 
| TSX contact: | Selma Thaver,  Managing Director, TSX Listings  | 
